Avoiding US FDA Import Alerts on Nutraceuticals Sourced from India
A fast-growing US supplement brand placed a massive order for a new ashwagandha gummy from an Indian manufacturer. The formulation was excellent, and the pricing gave them a 75% gross margin. The shipment left Nhava Sheva port on time. Six weeks later, it arrived at the Port of Long Beach - and never left.
The US Food and Drug Administration (FDA) detained the shipment. Why? Because the Indian manufacturing facility was listed on an FDA Import Alert for failing to renew their facility registration. The brand spent three weeks in customs purgatory, lost their launch window, and ultimately had to pay to have the entire container destroyed.
Sourcing nutraceuticals from India offers incredible R&D capability and commercial leverage, but the US border is unforgiving. If you are importing supplements from India, understanding and avoiding US FDA import alerts is the single most important supply chain skill you can master.
Here is what US brands and Indian manufacturers must do to ensure shipments clear customs without friction.
What is an FDA Import Alert?
When the FDA has evidence or a reasonable suspicion that a foreign facility, a specific product, or a specific importer is violating the Federal Food, Drug, and Cosmetic Act (FD&C Act), they issue an Import Alert.
Once a facility is on an Import Alert list (often referred to as being on the "Red List"), all shipments originating from that facility are subject to Detention Without Physical Examination (DWPE).
This means customs agents will automatically hold the container at the port. The burden of proof shifts entirely to the importer to hire third-party labs and legal counsel to prove the shipment is safe and compliant. This process is excruciatingly slow and often costs more than the value of the goods.
The 4 Most Common Reasons for Dietary Supplement Import Alerts
For Indian nutraceutical manufacturers and US brands importing their products, Import Alerts typically trigger for four specific reasons.
1. Facility Registration Failures (The "Easy" Mistake)
Every foreign facility that manufactures, processes, packs, or holds food (including dietary supplements) for consumption in the US must be registered with the FDA. This registration must be renewed biennially (every two years) between October 1 and December 31.
If a manufacturer forgets to renew, their registration is canceled. If they ship a product the following month, it hits the border, the FDA computers see an invalid facility number, and the shipment is instantly detained.
How to avoid it: Importers must independently verify their manufacturer's Facility Establishment Identifier (FEI) and registration status on the FDA website before placing every purchase order.
2. Unapproved New Drugs or Disease Claims
The FDA regulates dietary supplements as a sub-category of food, not drugs. Therefore, a supplement label cannot claim to "diagnose, mitigate, treat, cure, or prevent a specific disease or class of diseases."
If a gummy label says "Cures Insomnia" instead of "Supports Restful Sleep," or "Treats IBS" instead of "Supports Digestive Health," the FDA classifies the gummy as an "Unapproved New Drug." This immediately triggers an Import Alert.
How to avoid it: The manufacturer must understand the nuances of the US Dietary Supplement Health and Education Act (DSHEA). A qualified US regulatory consultant must review all label claims and the mandatory FDA disclaimer before the labels are printed in India.
3. Presence of Undeclared Allergens or Contaminants
If an Indian facility manufactures a gummy on shared equipment that also processes allergens (like dairy, soy, or tree nuts) without proper cleaning validation, and the FDA randomly tests the shipment and finds trace allergens not listed on the label, the facility will be flagged.
Furthermore, if the product tests positive for heavy metals (lead, arsenic, cadmium) or microbiological contamination (salmonella, E. coli), an Import Alert is guaranteed.
How to avoid it: The manufacturer must provide a comprehensive, batch-specific Certificate of Analysis (CoA) from an accredited third-party lab covering heavy metals and microbiology. The facility must also provide a signed Allergen Declaration.
4. Non-Compliant Labelling (Supplement Facts Panel)
The US FDA has highly specific formatting requirements for the "Supplement Facts" panel. If the label uses the EU "Nutritional Info" format, lists ingredients in the wrong order, or fails to properly identify the part of the plant used for botanical extracts, the shipment can be detained for misbranding.
How to avoid it: Never use an international or Indian domestic label template for a US-bound product. The manufacturer must have the capability to format compliant US Supplement Facts panels.
Explore Export-Ready Manufacturing
How to Audit an Indian Manufacturer for US Compliance
US FDA import alert avoidance nutraceuticals strategies begin during the manufacturer selection phase. Before signing a contract with an Indian CMO, you must audit their regulatory readiness.
Ask these specific questions:
- "What is your FEI Number?" Do not accept a vague "we are FDA approved" (the FDA does not "approve" facilities; they register them). Ask for the FEI number and verify it.
- "Have you been inspected by the FDA?" A facility that has successfully passed a physical FDA inspection and received an Establishment Inspection Report (EIR) with No Action Indicated (NAI) or Voluntary Action Indicated (VAI) is a high-tier facility.
- "Are you currently on any Import Alerts?" Check the FDA's public databases (specifically Import Alerts 99-19, 66-41, and 54-15) for the manufacturer's name.
- "Do you have a US Agent?" Every foreign facility must designate a US Agent for FDA communications. If they don't have one, their registration is invalid.
The Role of Foreign Supplier Verification Programs (FSVP)
The FDA's Food Safety Modernization Act (FSMA) introduced the Foreign Supplier Verification Program. This law shifts massive liability onto the US Importer.
Under FSVP, the US brand (or their designated importer) is legally required to perform risk-based activities to verify that the Indian manufacturer produces food in a manner providing the same level of public health protection as required under US law.
This means you cannot just blindly trust the Indian manufacturer. You must maintain a documented FSVP file that includes:
- Hazard analysis of the gummy formulation
- Review of the manufacturer's food safety history (including FDA warning letters)
- Verification activities (reviewing their CoAs, GMP certificates, or conducting third-party audits)
If the FDA audits the US Importer and finds no FSVP file for the Indian manufacturer, the importer is penalized, and future shipments may be detained.
FAQ
If my shipment is detained, can I just send it back to India? Yes, you can typically choose to export the detained shipment back to the origin country or destroy it. However, you will pay the return freight costs, and the Indian manufacturer will likely not refund the manufacturing cost unless the error was explicitly their contractual fault.
Does a US Customs broker guarantee my shipment will clear the FDA? No. A customs broker handles the logistics of filing entry paperwork and paying duties. They do not ensure regulatory compliance. If the product is misbranded or the facility is unregistered, the broker cannot stop the FDA from detaining it.
How do I get my manufacturer off the FDA Red List? This is a lengthy, expensive legal process known as a "Petition for Removal from DWPE." It requires hiring FDA counsel, providing extensive documentation proving the root cause of the violation has been corrected, and usually involves shipping several consecutive "clean" shipments that undergo rigorous third-party testing at the border. It takes months, sometimes years.
Sourcing Export-Ready Gummies from India
To successfully launch an Indian-manufactured gummy in the US market, you need a partner whose compliance infrastructure is as strong as their formulation science.
Our Mysuru facility is US-FDA registered, GMP-compliant, and experienced in preparing the comprehensive documentation required for frictionless US customs clearance.
If you are a US brand looking for a reliable, export-ready gummy manufacturing partner, share your brief with us.
Explore Functional Gummy Manufacturing Request a Project Brief
Want to discuss your formulation?
Our experts help brands launch technically complex probiotic and functional gummies.
